NCT07143279View on ClinicalTrials.gov

Testosterone Supplementation in Patients in Best Supportive Care: Impact on Quality of Life

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
HypotestosteronismPalliative Care
Interventions
DRUG

Sustanon 250

Sustanon 250® (1 ml, IM) every 10 days

Sponsors
All Listed Sponsors
lead

Jules Bordet Institute

OTHER